These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 19068391)
21. [Histological changes in normal and cancerous prostate after treatment (hormone therapy and radiotherapy) and their impact on the interpretation of the Gleason Score]. Molinié V Prog Urol; 2006 Feb; 16(1 Suppl):10-5. PubMed ID: 16615312 [No Abstract] [Full Text] [Related]
22. Gleason Pattern 5 prostate cancer: further stratification of patients with high-risk disease and implications for future randomized trials. Nanda A; Chen MH; Renshaw AA; D'Amico AV Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1419-23. PubMed ID: 19131185 [TBL] [Abstract][Full Text] [Related]
23. [Treatment of prostatic cancer with high intensity focused ultrasound (HIFU) using Ablatherm device]. Aliaev IuG; Krupinov GE; Bezrukov EA; Grigorian VA; Amosov AV; Chalyĭ ME; Kobzev DN; Bruk IuF; Shestiperov PA Urologiia; 2007; (6):39-44. PubMed ID: 18649659 [TBL] [Abstract][Full Text] [Related]
24. Salvage radical prostatectomy for recurrent prostate cancer after radiation therapy. Leonardo C; Simone G; Papalia R; Franco G; Guaglianone S; Gallucci M Int J Urol; 2009 Jun; 16(6):584-6. PubMed ID: 19453762 [TBL] [Abstract][Full Text] [Related]
25. Radical prostatectomy for high-risk prostate cancer: biochemical outcome. Kawamorita N; Saito S; Ishidoya S; Ito A; Saito H; Kato M; Arai Y Int J Urol; 2009 Sep; 16(9):733-8. PubMed ID: 19674167 [TBL] [Abstract][Full Text] [Related]
26. Targeted focal therapy for prostate cancer: a review. Hou AH; Sullivan KF; Crawford ED Curr Opin Urol; 2009 May; 19(3):283-9. PubMed ID: 19357510 [TBL] [Abstract][Full Text] [Related]
27. Minimally invasive surgical approaches and management of prostate cancer. Gonzalgo ML; Patil N; Su LM; Patel VR Urol Clin North Am; 2008 Aug; 35(3):489-504, ix. PubMed ID: 18761202 [TBL] [Abstract][Full Text] [Related]
28. Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy. Zhang Q; Helfand BT; Jang TL; Zhu LJ; Chen L; Yang XJ; Kozlowski J; Smith N; Kundu SD; Yang G; Raji AA; Javonovic B; Pins M; Lindholm P; Guo Y; Catalona WJ; Lee C Clin Cancer Res; 2009 May; 15(10):3557-67. PubMed ID: 19447876 [TBL] [Abstract][Full Text] [Related]
29. Salvage laparoscopic surgery in advanced prostate cancer: is it possible or beneficial? Patel HR; Amodeo A; Joseph JV Expert Rev Anticancer Ther; 2008 Sep; 8(9):1509-13. PubMed ID: 18759701 [TBL] [Abstract][Full Text] [Related]
30. [Oncologic and functional outcomes after radical prostatectomy in T3 prostate cancer]. Xylinas E; Misraï V; Comperat E; Renard-Penna R; Vaessen C; Bitker MO; Chartier-Kastler E; Richard F; Cussenot O; Rouprêt M Prog Urol; 2009 May; 19(5):285-90. PubMed ID: 19393531 [TBL] [Abstract][Full Text] [Related]
31. [Surgery of locally advanced prostate cancer]. Soulié M; Thoulouzan M; Péneau M; Richaud P; Ravery V; Prog Urol; 2008 Dec; 18(13):1031-7. PubMed ID: 19041806 [TBL] [Abstract][Full Text] [Related]
32. Population-based study of biochemical and survival outcomes after permanent 125I brachytherapy for low- and intermediate-risk prostate cancer. Morris WJ; Keyes M; Palma D; Spadinger I; McKenzie MR; Agranovich A; Pickles T; Liu M; Kwan W; Wu J; Berthelet E; Pai H Urology; 2009 Apr; 73(4):860-5; discussion 865-7. PubMed ID: 19168203 [TBL] [Abstract][Full Text] [Related]
33. Long-term follow-up after triple treatment of prostate cancer stage pT3. Schelin S; Madsen M; Palmqvist E; Mäkelä E; Klintenberg C; Aus G Scand J Urol Nephrol; 2009; 43(3):186-91. PubMed ID: 19353383 [TBL] [Abstract][Full Text] [Related]
35. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation. Demanes DJ; Brandt D; Schour L; Hill DR Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902 [TBL] [Abstract][Full Text] [Related]
36. Cancer ablation with regional templates applied to prostatectomy specimens from men who were eligible for focal therapy. Ward JF; Nakanishi H; Pisters L; Babaian RJ; Troncoso P BJU Int; 2009 Aug; 104(4):490-7. PubMed ID: 19220260 [TBL] [Abstract][Full Text] [Related]
37. Salvage robotic-assisted radical prostatectomy: initial results and early report of outcomes. Boris RS; Bhandari A; Krane LS; Eun D; Kaul S; Peabody JO BJU Int; 2009 Apr; 103(7):952-6. PubMed ID: 19076132 [TBL] [Abstract][Full Text] [Related]
38. Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy. Aaronson DS; Yamasaki I; Gottschalk A; Speight J; Hsu IC; Pickett B; Roach M; Shinohara K BJU Int; 2009 Sep; 104(5):600-4. PubMed ID: 19245439 [TBL] [Abstract][Full Text] [Related]
39. Effects of short-term finasteride on apoptotic factors and androgen receptors in prostate cancer cells. Bass R; Perry B; Langenstroer P; Thrasher JB; Dennis KL; Tawfik O; Holzbeierlein J J Urol; 2009 Feb; 181(2):615-9; discussion 619-20. PubMed ID: 19091346 [TBL] [Abstract][Full Text] [Related]
40. Intralesional recombinant alpha-interferon for localized prostate cancer: a pilot study with follow-up of >10 years. Emerson L; Morales A BJU Int; 2009 Oct; 104(8):1068-70. PubMed ID: 19338545 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]